User:JSFarman/sandbox/Alexandra M. Levine

Alexandra M. Levine is an American oncologist and researcher. The chief medical officer of City of Hope, her research focuses on lymphoma, Hodgkin's Disease, and AIDS-related malignancies. She began treating people with AIDS in the early 1980s. In a 1921 article about the pioneers of AIDS care, published in the New England Journal of Medicine, and the environment at the time, Levine the horror of society as a whole turned its back on this suffering, the horror of watching as many of my own colleagues refused to help, refused to care, and refused to act as the professionals they were supposed to be."

Considered a pioneer of AIDSLevine began treating people with AIDS and HIV

She has published more than 300 articles and chapters, was elected as a Master of the American College of Physicians in 2009 and is a member of the Oncologic Drug Advisory Board of the U.S. Food and Drug Administration. She was also appointed to former Pres. Clinton’s Presidential Advisory Council on HIV/AIDS and served as an HIV/AIDS consultant to the health departments of Chile, Russia, India and China.

y City of Hope’s chief medical officer – back to the biomedical research, treatment and education institution that fights diseases such as cancer, diabetes and HIV/AIDS some 40 years later.

Levine formerly served as a distinguished professor and chair of the Division of Hematology at USC’s Keck School of Medicine and as the medical director of the USC/Kenneth Norris Jr. Cancer Hospital.

Worked with Jonas Salk on AIDS vaccine in 1988

She is an expert recognized nationally and internationally for her research on blood cancers and blood diseases as well as HIV/AIDS-related malignancies. She has even worked with her mentor Dr. Jonas Salk on the development and testing of an AIDS vaccine.

Alexandra Levine, chief of hematology at the University of Southern California School of Medicine and a researcher on HIV in women, said her own findings suggest nonmedical factors play a big role in how infected women fare. - non medical factors- Twice as often in women as in men, death was the first sign that HIV was progressing,

Alexandra Levine, M.D., M.A.C.P., is a professor in City of Hope’s Hematologic Malignancies and Stem Cell Transplantation Institute, which includes the Judy and Bernard Briskin Center for Multiple Myeloma Research, Toni Stephenson Lymphoma Center and Gehr Family Center for Leukemia Research. Dr. Levine is an acclaimed expert in lymphoma, Hodgkin's disease and AIDS-related malignancies. She has published over 325 articles in peer-reviewed literature and was consistently funded as a principal investigator by the National Institutes of Health from 1982 to 2012. She worked with Dr. Jonas Salk for eight years on testing and developing an AIDS vaccine. In 1995, President Bill Clinton appointed her to the Presidential Advisory Council on HIV/AIDS, and she has also served on the National Cancer Institute's Board of Scientific Counselors from 1996 to 1999 and from 2010 to 2015. Internationally, she has consulted for the health departments of Chile, Russia, India and China. Dr. Levine is an advocate for humanism in medicine who works tirelessly to perpetuate the City of Hope message of comprehensive, compassionate care.

Alexandra M. Levine, MD, graduated Phi Beta Kappa from the University of California, Berkeley, and then from the University of Southern California (USC) school of medicine, where she was elected to Alpha Omega Alpha. She received training in internal medicine and hematology at USC, and in oncology at Emory University. Levine joined the staff at USC in 1977, where she is currently a professor of medicine. Levine served as the executive associate dean of the USC school of medicine from 1985 to 1990, and is currently chief of the division of hematology. She also serves as medical director of the USC/Norris Cancer Hospital. Levine's research interests include hematologic malignancies and HIV disease; she has published over 150 articles and over 50 book chapters on the topic. Levine began an active program of AIDS research in 1981, focused primarily on the cancers related to AIDS, and most recently on HIV disease in women. She has worked with Jonas Salk, MD, in the development and testing of a therapeutic AIDS vaccine. Levine is a member of the Board of Scientific Counselors of the National Cancer Institute. She was appointed to the Presidential HIV/AIDS Advisory Council by President Clinton in June, 1995. Levine serves as chair of the Research Committee for the Presidential Council.

Other things had happened in her life. Both her parents died of cancer in the late 1980s--”the one time in my life when I just couldn’t be optimistic.” She drifted into administration for a while, to avoid dealing with cancer patients, and she did a lot of thinking about her relationships with the dying.